Portfolio Management Reports
Create robust counter-generics strategies to retain products’ market share and prevent revenue erosion after patent expiration.
Create a strong commercial voice to best position developing brands for future success.
Master portfolio management and drive coordinated execution using benchmarks and best practices from pre-clinical to end of life.
Reinforce business development and licensing capabilities to capitalize on deal opportunities, drive successful negotiations and foster lucrative pharmaceutical and biotechnology partnerships.
Prolong brand life and defend market share with bold lifecycle management that supports products from pre-launch to post-patent.
Realize deal value, target the right pharma acquisition opportunities and complete post-M&A integration as quickly as possible.
Craft a robust alliance management strategy to bridge organizational gaps and drive pharma partnership project success while preparing for contingencies.
Uncover the strategy, science, investments and timing behind common relaunch strategies.